Skip to main content

CORRECTION article

Front. Cardiovasc. Med., 15 December 2022
Sec. Cardiovascular Biologics and Regenerative Medicine

Corrigendum: Accelerated cardiac aging in patients with congenital heart disease

  • Bristol Medical School, Faculty of Health Sciences, University of Bristol, Bristol, United Kingdom

A corrigendum on
Accelerated cardiac aging in patients with congenital heart disease

by Iacobazzi, D., Alvino, V. V., Caputo, M., and Madeddu, P. (2022). Front. Cardiovasc. Med. 9:892861. doi: 10.3389/fcvm.2022.892861

In the published article, there was an error in the Funding statement. The BHF Funding grant number was missing. The correct Funding statement appears below.

Funding

This study was supported by the grants from the Sir Jules Thorn Charitable Trust (MC and PM), the Enid Linder Foundation (MC), the National Institute for Health Research (NIHR) Bristol Biomedical Research Centre in Cardiovascular Medicine (MC and PM), the British Heart Foundation (no. PG/18/38/33707) grant entitled “Microfabrication and in vivo testing of small-diameter tissue-engineered vascular grafts” (PM), and the Medical Research Council (no. MR/N027086/1) grant entitled “In vitro and in vivo preclinical testing of pericyte-engineered grafts for correction of congenital heart defects” (PM and MC).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: aging, congenital defect, proteostasis, inflammation, surgery, extracorporeal bypass

Citation: Iacobazzi D, Alvino VV, Caputo M and Madeddu P (2022) Corrigendum: Accelerated cardiac aging in patients with congenital heart disease. Front. Cardiovasc. Med. 9:1112510. doi: 10.3389/fcvm.2022.1112510

Received: 30 November 2022; Accepted: 05 December 2022;
Published: 15 December 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Iacobazzi, Alvino, Caputo and Madeddu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Paolo Madeddu, yes paolo.madeddu@bristol.ac.uk

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.